Metronidazol Serraclinics

Metronidazole, the active ingredient in Metronidazol Serraclinics, is a nitroimidazole antibiotic presented as an injectable solution for intravenous use. It treats anaerobic bacterial infections and certain protozoal diseases in adults and children as prescribed.

GNH USA supplies Metronidazol Serraclinics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazol Serraclinics is a nitroimidazole antibiotic used to manage infections caused by anaerobic bacteria and selected protozoa.

- Anaerobic bacterial infections: effective against intra‑abdominal, pelvic and skin‑soft tissue infections caused by anaerobes. - Clostridioides difficile infection: helps resolve moderate to severe C. difficile‑associated diarrhea. - Bacterial vaginosis: restores normal vaginal flora by eliminating Gardnerella species. - Trichomoniasis: eradicates Trichomonas vaginalis in genital infections. - Amebic liver abscess: eliminates Entamoeba histolytica in hepatic lesions.

Metronidazol Serraclinics may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis or angioedema. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before using Metronidazol Serraclinics, consider the following precautions.

- Pregnancy: Category B – use only if the potential benefit justifies the potential risk to the fetus. - Breastfeeding: Caution – drug is excreted in breast milk; assess risk versus benefit. - Renal impairment: Monitor renal function; dose adjustment may be required. - Alcohol consumption: Avoid concurrent alcohol to prevent a disulfiram‑like reaction. - Drug interactions: Review concomitant medications for potential interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metronidazol Serraclinics can interact with several medicines.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, nausea, vomiting, and tachycardia. - Warfarin: increased anticoagulant effect, raising bleeding risk. - Lithium: heightened lithium toxicity, requiring close monitoring.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Rifampin: may reduce metronidazole effectiveness by increasing metabolism.